Biogen Inc. (NASDAQ:BIIB) Receives Average Rating of "Moderate Buy" from Analysts

Biogen Inc. (NASDAQ:BIIB – Get Free Report) has received an average recommendation of “Moderate Buy” from the twenty-six ratings firms that are covering the company, MarketBeat Ratings reports. Nine analysts have rated the stock with a hold recommendation and seventeen have given a buy recommendation to the company. The average 12-month target price among brokerages […]

Related Keywords

United States , Germany , Wellington , New Zealand General , New Zealand , America , Piper Sandler , Vanguard Group Inc , Northern Trust Corp , Biogen Inc , Wellington Management Group , Nasdaq , Biogen Company Profile , Primecap Management Co , Associates Corp , Get Free Report , Marketbeat Ratings , Truist Financial , Management Group , Trust Corp , Trading Down , Get Free , Biogen Daily ,